Reliance on the Zhang CD8 TCS signature for all cancers as a prognostic indicator for OS and PFI could provide valuable insight into future cancer behavior, however, our study demonstrates the importance of consideration of numerous published signatures tailored to tumor type and origin to better inform patient-centered decision-making. The gene discussed is CD8A; the disease is neoplasm.